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Role Of Hif2α Oxygen Sensing 
Pathway In Bronchial Epithelial 
Club Cell Proliferation
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Florinda Melendez Rodriguez1, Tamara Alonso3, Francisco Sanchez-Madrid1,  
Francisco García-Rio4, Julio Ancochea3 & Julián Aragonés1
Oxygen-sensing pathways executed by the hypoxia-inducible factors (HIFs) induce a cellular adaptive 
program when oxygen supply becomes limited. However, the role of the HIF oxygen-sensing pathway 
in the airway response to hypoxic stress in adulthood remains poorly understood. Here we found that 
in vivo exposure to hypoxia led to a profound increase in bronchial epithelial cell proliferation mainly 
confined to Club (Clara) cells. Interestingly, this response was executed by hypoxia-inducible factor 
2α (HIF2α), which controls the expression of FoxM1, a recognized proliferative factor of Club cells. 
Furthermore, HIF2α induced the expression of the resistin-like molecules α and β (RELMα and β), 
previously considered bronchial epithelial growth factors. Importantly, despite the central role of 
HIF2α, this proliferative response was not initiated by in vivo Vhl gene inactivation or pharmacological 
inhibition of prolyl hydroxylase oxygen sensors, indicating the molecular complexity of this response 
and the possible participation of other oxygen-sensing pathways. Club cells are principally involved 
in protection and maintenance of bronchial epithelium. Thus, our findings identify a novel molecular 
link between HIF2α and Club cell biology that can be regarded as a new HIF2α-dependent mechanism 
involved in bronchial epithelium adaptation to oxygen fluctuations.
Cellular adaptation to oxygen fluctuations is driven by oxygen-sensing pathways such as those mediated by the 
hypoxia-inducible factors (HIF1, HIF2 and HIF3), central regulators of the transcriptional response to hypoxia. 
Under normoxic conditions, prolyl hydroxylases (PHD− 1,− 2 and − 3) use oxygen to hydroxylate critical proline 
residues in HIFα subunits, which ultimately leads to their recognition by the von Hippel-Lindau (Vhl) protein 
and subsequent degradation by the proteasome1–4. Additionally, the asparagine hydroxylase, factor inhibiting HIF 
(FIH), hydroxylates the C-terminal domain of HIFα subunits, which prevents the binding of the transcriptional 
coactivator p300 and therefore HIF transactivation potential5,6. PHD and FIH activities are reduced in hypoxia 
and HIFα subunits accumulate and activate HIF-dependent transcriptional programs. Accordingly, pharma-
cological inhibition of PHD and FIH activities or inactivation of Vhl, Phd or Fih genes, results in constitutive 
normoxic stabilization or activity of HIF transcription factors5–8.
Erythropoiesis and angiogenesis are archetypal adaptive physiological responses to hypoxia, mediated largely 
by the ability of HIFs to govern the expression of erythropoietin (EPO)9 and vascular endothelial growth factor 
(VEGF)10. Inhibition of cell-autonomous replication is an additional classic response to hypoxia; indeed, hypoxia 
attenuates cell proliferation in several different cell types11. Several mechanisms have been proposed to promote 
this antiproliferative action including HIF1α -dependent inhibition of c-MYC activity12,13 or repression of DNA 
replication by a HIF1α -dependent non-transcriptional mechanism that ultimately compromises the activity 
of MCM DNA helicase14. Furthermore, inhibition of PHD1 reduces cyclinD1 expression in breast cancer cells 
independently of HIF15, and promotes cell cycle arrest through regulation of the centrosomal scaffold protein 
CEP19216. Reduced oxygen environments and subsequent activation of the HIF pathway are not, however, invar-
iably associated with attenuation of cell cycle and proliferation. For example, hypoxia promotes the proliferation 
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of neural stem cells (NSC)17,18. Indeed, HIF1α plays a significant role in regulating cell-autonomous NSC prolifer-
ation via modulation of the expression of the β -catenin effectors LEF-1 and TCF-1, and enhances Wnt/ β -catenin 
proliferative signalling19. Additionally, in Vhl-deficient renal carcinoma cells, HIF2α promotes cell-autonomous 
proliferation and tumour growth12,20–22.
The role of the HIF oxygen sensing pathways in lung biology has been mainly associated with pulmonary 
hypertension as a consequence of HIF-dependent pulmonary artery smooth muscle cell (PASMC) prolifer-
ation and vascular remodelling in response to chronic hypoxia (several weeks)23,24. However, the role of HIF 
oxygen-sensing pathways in the response of lung conducting airways to hypoxic stress remains largely unknown. 
Nevertheless, a recent study has shown that lower HIF2α levels are associated with multiple severity pheno-
types of chronic obstructive pulmonary disease (COPD) in humans, and emphysema severity-associated genes 
in mice25. Along this line, it was recently found that loss of the HIF2α isoform in airway cells leads to enhanced 
airway inflammation upon lung injury26. In the present study, we have identified Club (Clara) bronchial epithelial 
cells, previously involved in the maintenance and protection of bronchial epithelium, as a novel cell type that dis-
plays a remarkable proliferative potential upon in vivo exposure to hypoxia. This response requires HIF2α , which 
leads to the upregulation of FoxM1 as well as the established bronchial epithelial cell growth factors RELMα and 
RELMβ . However, HIF2α activation by pharmacological inhibition of PHD activity is not sufficient to induce 
Club cell proliferation. Our data therefore demonstrate that proliferation of bronchial Club cells is part of the 
biological responses initiated by the HIF2α oxygen-sensing pathway in lung tissue.
Results
Hypoxia induces proliferation of bronchial epithelial cells. Lung is the first-line contact organ with 
oxygen but the responses of lung conducting airways to hypoxic stress in vivo remains poorly understood. It 
is recognized that chronic hypoxia promotes pulmonary vascular smooth muscle cell proliferation, leading to 
vascular remodelling and pulmonary hypertension27. Here, we studied the pulmonary responses to oxygen 
fluctuations in mice subjected to hypoxia (10% O2), but at shorter time points (1-4 days). We first studied cell 
proliferation in lungs from mice exposed to normoxia or hypoxia by staining lung sections with the cell cycle-as-
sociated protein Ki67, a marker of cell proliferation. Surprisingly, immunohistochemistry analysis showed a clear 
increase in the number of Ki67positive cells in lung conducting airways after exposure of mice to hypoxia for 3 
days, and this was particularly manifested in the bronchial epithelium (Fig. 1A). Quantification of Ki67 staining 
revealed that after 3 days of hypoxia exposure, approximately 10-15% of bronchial epithelial cells were Ki67positive 
(Fig. 1B). Moreover, this response required more than 1 day to be mounted because no increase in the number 
of Ki67positive bronchial epithelial cells after 1 day of hypoxia exposure was detected (Fig. 1B). To confirm that 
hypoxic bronchial epithelial cells enter into a proliferative state, mice were exposed to hypoxia or normoxia and 
injected intraperitoneally with the DNA synthesis marker BrdU. Analysis of BrdU staining in lung sections from 
hypoxic animals showed the appearance of BrdUpositive cells in hypoxic lung conducting airways that was evident 
in bronchial epithelial cells (Fig. 1C). Quantification of BrdUpositive bronchial epithelial cells revealed a significant 
increase in their percentage in mice exposed to hypoxia (Fig. 1D). Collectively, these data show that low oxygen 
tension in vivo initiates a rapid proliferative response in lung conducting airway cells, which is particularly evi-
dent in bronchial epithelial cells.
Hypoxia induces proliferation of bronchial Club epithelial cells. Club cells and ciliated cells are two 
essential cell types of the bronchial epithelium, and they can be detected using specific markers. Accordingly, 
Club cells are detected with a specific antibody against CC10, a secretory product also known as secretoglo-
bin family 1A member 1 (SCGB1A1)28, whereas ciliated cells are detected with a specific antibody against 
acetyl-tubulin, a protein expressed in primary and motile cilia within the cytoplasm28. We used these mark-
ers to determine whether bronchial epithelial cell proliferation in hypoxic lungs was preferentially due to 
any of these bronchial epithelium cell types. Thus, lung sections of mice subjected to hypoxia for 3 days were 
co-stained with antibodies against Ki67, CC10 and acetyl-tubulin to assess proliferation in Club or ciliated cells, 
respectively. Immunohistochemistry analysis revealed that the majority of Ki67positive signals were confined to 
CC10positive cells (Fig. 2A). By contrast, the number of cells with double-positive Ki67/acetyl-tubulin staining 
was less abundant (Fig. 2A). Quantification of the signals showed that 78.31 ± 3.54% of Ki67positive cells were 
CC10positive cells whereas only 8.11 ± 1.36% were acetyl-tubulinpositive cells (Fig. 2B). This analysis also detected the 
presence of some Ki67positive cells located in the basal lamina lacking the expression of CC10 and acetyl-tubulin 
(13.58 ± 2.63%), possibly reflecting some proliferation in bronchial epithelium basal stem cells. Collectively, these 
data clearly indicate that low oxygen tension induces bronchial epithelium proliferation in vivo, which is mainly 
confined to Club cells.
Hypoxia-induced bronchial epithelial cell proliferation requires HIF2α. Club cells and their secre-
tory protein CC10 are mainly orientated towards the protection of the respiratory tract, and serum levels of 
CC10 are reduced in individuals with COPD29,30. Furthermore, recent studies have shown that lower levels of 
HIF2α are associated with COPD severity in human and mice25. Considering that rodent lung tissue expresses 
high levels of HIF2α RNA31, we hypothesized that the HIF2α oxygen-sensing pathway could have a direct role 
in hypoxia-driven bronchial epithelial cell proliferation. We performed an immunofluorescence analysis to 
assess whether HIF2α was expressed in hypoxic bronchial epithelium. Our analysis localized a robust HIF2α 
signal in the nuclei of bronchial epithelial cells of hypoxic lungs, while this nuclear signal was barely present 
in normoxic lungs (Fig. 3A). Therefore, these data show that both hypoxia-driven bronchial epithelium prolif-
eration as well as the appearance of nuclear HIF2α is observed in bronchial epithelial cells. To investigate the 
involvement of HIF2α in bronchial epithelial cell proliferation, we performed Ki67 staining in lung sections of 
control mice and HIF2α floxed-Ubc-Cre-ERT2 mice (HIF2α f/f deficient mice), in which the HIF2α locus can be 
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acutely inactivated in adult mice22. Indeed, in this study, HIF2α gene expression was reduced by 90.6 ± 1.9% 
in HIF2α floxed-Ubc-Cre-ERT2 relative to control mice. Consistent with earlier results (Fig. 1B), the number of 
Ki67positive cells increased significantly in response to hypoxia in control mice, but this response was completely 
abolished in HIF2α f/f deficient mice (Fig. 3B,C). These data show that HIF2α is required for hypoxia-induced 
bronchial epithelium proliferation.
Regarding potential HIF2α downstream events that could be involved in this proliferative response, we first 
considered previous in vivo studies showing that the FoxM1 transcription factor is critical for proliferation and 
differentiation of Club cells32,33. RNA analysis showed that FoxM1 RNA levels were induced by hypoxia in control 
mice, but this response was impaired in HIF2α f/f deficient mice (Fig. 4A). Moreover, we also considered previ-
ous in vitro studies implicating several soluble factors in bronchial epithelium proliferation, such as resistin-like 
molecules (RELM), epithelial growth factor (EGF) and hepatic growth factor (HGF)34–37. RNA analysis showed 
that the expression levels of RELMα and RELMβ in control mice were significantly higher in hypoxia than in 
normoxia, whereas EGF and HGF were unaffected by oxygen tension (Fig. 4B). Western blotting revealed that 
whereas RELMα protein was undetectable in normoxic lungs, it was strongly induced after 3 days of hypoxia 
(Fig. 4C). Hypoxia-induced expression of RELMα RNA and protein was completely abolished in HIF2α f/f defi-
cient mice, showing that its expression is HIF2α dependent in hypoxic lungs (Fig. 4B,C). Immunohistochemistry 
analysis further showed that HIF2α -dependent RELMα expression was largely localized to bronchial epithelium 
(Fig. 4D). Overall, these data show that HIF2α activity is required for epithelial cell proliferation in hypoxic bron-
chial epithelium, and controls key regulators of Club cell proliferation, such as FoxM1, as well as the previously 
established bronchial epithelium mitogen RELMα .
Vhl gene inactivation or pharmacological inhibition of PHD oxygen sensors is not sufficient 
to induce bronchial epithelial cell proliferation. Since Club cells are associated with respiratory tract 
protection, we next questioned whether constitutive HIF2α activation in normoxia was sufficient to promote 
Club cell proliferation. To do this, we used adult Vhlfloxed-Ubc-Cre-ERT2 mice in which the expression of Vhl, a 
central repressor of HIF activity, can be acutely inactivated and leads to an elevated expression of HIFα protein 
subunits in lung22. To corroborate that Vhl inactivation also leads to HIF2α activity in lung, the expression of 
Figure 1. Hypoxia induces proliferation of bronchial epithelial cells. (A) Ki67 immunostaining in lung 
sections of control mice exposed to normoxia or hypoxia (10% O2) for 3 days. Red arrowheads indicate 
Ki67positive bronchial epithelial cells. Images of the lower panels are higher magnification of those in the upper 
panels. (B) Quantification of Ki67positive bronchial epithelial cells in lung of control mice exposed to normoxia 
(n = 15) or hypoxia 10% O2 (n = 15) for 1 day as well as to normoxia (n = 12) or hypoxia 10% O2 (n = 16) for 3 
days. (C) BrdU immunofluorescence in the lung of control mice exposed to normoxia or hypoxia (10% O2)  
for 4 days. (D) Quantification of BrdUpositive bronchial epithelial cells in lung of control mice exposed to 
normoxia (n = 5) or hypoxia 10% O2 (n = 5) for 4 days. For (B,D), n indicates the number of bronchial epithelia 
examined; the mean is shown, and error bars represent SEM. Statistical significance was assessed by the two-
tailed Student’s t test: **p < 0.01; ***p < 0.001; ns (not significant). Scale bars: (A) Upper panel, 50 μ m, lower 
panel, 20 μ m; (C), 50 μ m.
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Figure 2. Hypoxia induces proliferation of bronchial Club epithelial cells. (A) Immunofluorescence of Club 
(CC10, purple), ciliated (acetyl-tubulin, green) and proliferative cells (Ki67, red) in lung sections of control 
mice exposed to hypoxia (10% O2) for 3 days (left panel). Consecutive lung section stained with CC10 (purple) 
and acetyl-tubulin (green) antibodies together with DAPI (blue) to localize nuclei of bronchial epithelial cells 
(middle panel). In the right panel, a representation indicating the meaning of the dotted lines is shown.  
(B) Quantification of Ki67positive ciliated or Club cells relative to total Ki67positive bronchial epithelial cells 
(n = 20). n indicates the number of bronchial epithelia examined. Values are expressed as mean ± SEM and 
unpaired Student’s t test was used for statistical analysis: ***p < 0.001. Scale bar: 10 μ m.
Figure 3. Hypoxia-induced bronchial epithelial cell proliferation requires HIF2α. (A) HIF2α 
immunostaining in lung sections of control mice exposed to normoxia or hypoxia (10% O2) for 3 days. DAPI 
nuclear counterstaining shows colocalization of HIF2α and nuclei signal of hypoxic bronchial epithelial 
cells (yellow arrowheads). (B) Immunostaining for Ki67 in lung sections of control or HIF2α -deficient mice 
(HIF2α floxed-Ubc-Cre-ERT2) exposed to normoxia or hypoxia (10% O2) for 3 days. Red arrowheads indicate 
Ki67 positive bronchial epithelial cells. (C) Quantification of Ki67 positive bronchial epithelial cells in control 
exposed to normoxia (n = 10) or hypoxia 10% O2 (n = 11) for 3 days or HIF2α -deficient mice exposed to 
normoxia (n = 18) or hypoxia 10% O2 (n = 31) for 3 days. n indicates the number of bronchial epithelia 
analysed. Values are expressed as mean ± SEM and statistical significance was assessed by the One-way ANOVA 
Tukey’spost test. ***p < 0.001. Scale bars: (A), 10 μ m; (B), upper panel, 50 μ m, lower panel, 20 μ m.
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RELMα was evaluated as a HIF2α -dependent gene in Vhlfloxed-Ubc-Cre-ERT2 mice. RELMα gene expression in 
lung was significantly increased in these mice as in hypoxia-exposed mice (Fig. 5A). Furthermore, consistent with 
its localization in control mice, immunohistochemistry analysis revealed that RELMα protein expression was 
confined largely to the bronchial epithelium in Vhl-deficient mice (Fig. 5B). Therefore, Vhlfloxed-Ubc-Cre-ERT2 
mice accurately mimic the phenotype of hypoxia-induced HIF2α activity measured as RELMα expression in 
the bronchial epithelium. Nevertheless, in contrast to hypoxia-treated mice, the number of Ki67positive cells in 
the bronchial epithelium was not elevated in Vhl-deficient mice (Fig. 5B). These data suggest that HIF2α activa-
tion in Vhl-deficient mice is not sufficient to promote bronchial epithelium proliferation. Therefore, as a second 
approach to induce HIF2α activity in lung, we treated mice with dimethyloxalylglycine (DMOG), a competitive 
inhibitor of PHD oxygen sensors. The expression of RELMα was also evaluated as a readout of HIF2α activity 
in DMOG-treated mice. Pulmonary RELMα expression was elevated both at the RNA level (Fig. 5A) and at the 
protein level, and protein expression was mainly localized at the bronchial epithelium (Fig. 5B). Thus, DMOG 
treatment also mimicked the effect of hypoxia on HIF2α activity and RELMα expression in the bronchial epi-
thelium. The efficacy of DMOG treatment was also evaluated by its ability to induce Epo gene expression in the 
kidneys of these DMOG-treated mice (Supplemental Fig. 1). Nevertheless, DMOG treatment failed to increase 
the number of Ki67positive cells in the bronchial epithelium. Collectively, these results indicate that although HIF2α 
is required to promote Club cell proliferation, it is not sufficient.
In conclusion, our data identify a novel molecular response initiated by HIF2α , which promotes the pro-
liferation of Club cells, which are known to be involved in bronchial epithelial maintenance and protection. 
Importantly, our findings also reveal that HIF2α activation is required but it is not sufficient to mount this pro-
liferative response, underscoring the molecular complexity of this oxygen-dependent pulmonary proliferative 
response.
Figure 4. Hypoxia induces FoxM1 and RELMα in hypoxic lungs through HIF2α. (A) Relative FoxM1 
mRNA levels (normalized to those of Hprt) in the lungs of control mice exposed to normoxia (n = 4) or hypoxia 
10% O2 (n = 6) for 3 days or HIF2α -deficient mice exposed to normoxia (n = 3) or hypoxia 10% O2 (n = 4) for 
3 days. (B) Relative RELM-α , RELM-β , EGF and HGF mRNA levels (normalized to that of Hprt) in the lungs 
of control mice exposed to normoxia (n = 3) or hypoxia 10% O2 (n = 4) for 3 days or HIF2α -deficient mice 
exposed to normoxia (n = 3) or hypoxia 10% O2 (n = 4) for 3 days. (C) Western blot analysis of RELM-α and 
β –actin protein levels in the lungs of control or HIF2α -deficient mice exposed to normoxia or hypoxia (10% 
O2) for 3 days. A representative western blot is shown. (D) RELM-α immunohistochemistry in lung sections of 
control or HIF2α -deficient mice exposed to normoxia or hypoxia (10% O2) for 3 days. For (A,B) panels values 
are expressed as mean ± SEM and n is the number of the animals analysed. Error bars show 95% confidence 
interval based on duplicated samples. One-way ANOVA Tukey’spost test was used for statistical analysis. 
*p < 0.05; **p < 0.01; ns (not significant). For (D) panel, scale bar: 50 μ m.
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Discussion
Pulmonary HIF oxygen sensing pathways are associated with vessel remodelling and pulmonary hypertension 
in response to chronic hypoxia23,24,38. However, their role in the response of lung conducting airways to hypoxic 
stress in adulthood is largely unknown. Here we show that the HIF2α isoform promotes bronchial epithelial 
cell proliferation soon after hypoxia exposure and is mainly confined to Club cells. A recent study has shown 
that lower HIF2α levels are associated with multiple COPD severity phenotypes in human and emphysema 
severity-associated genes in mouse25. This, together with the contribution of Club cells to the long-term main-
tenance and repair of lung airway epithelium, by proliferating in response to epithelial damage to reconstitute 
injured airways39, suggest a possible reparative role for Club cells in lung disease involving the HIF2α isoform. 
Moreover, oxidative damage of the lung has emerged as a novel primary mechanism leading to lung damage in 
COPD and hypoxic lung injury40. Indeed, reactive oxygen species (ROS) from cigarette smoke are proposed 
as a primary cause of an amplified inflammation leading to apoptosis and irreversible lung damage40,41. It is 
also important to stress that the HIF2α pathway can also counteract oxidative damage in different biological 
settings7,42. In this context, it is important to consider that Club cells and their secretory protein CC10 have 
been shown to have lung protective properties43–45. Indeed, prolonged exposure to cigarette smoke reduces Club 
cell activity and CC10 levels in bronchoalveolar lavage fluids of healthy smokers43 and reduced CC10 levels 
are associated with oxidative stress and inflammation that results in reduced pulmonary function and COPD 
development44. Furthermore, serum levels of CC10 are reduced in individuals with COPD and are considered a 
Figure 5. Vhl gene inactivation or DMOG treatment does not induce bronchial epithelium proliferation. 
(A) Relative RELMα mRNA levels (normalized to those of Hprt) in mice exposed to normoxia (n = 3) or 
hypoxia 10% O2 (n = 6) for 3 days, Vhl deficient mice (n = 9) and their corresponding control mice (n = 9) 
as well as DMOG treated mice (n = 3) or vehicle-treated mice (n = 2). (B) Immunofluorescence of RELM-α 
(purple) or Ki67 (red) in lung of control mice, hypoxia-exposed mice (10% O2 for 3 days), Vhl-deficient mice 
and DMOG-treated mice. Data shown are means ± SEM and n is the number of mice examined. Error bars 
show 95% confidence interval based on duplicated samples. The differences between groups with similar 
variances were analysed with a two-tailed Student´s t-test:**p < 0.01; ***p < 0.001. Scale bars: (B), upper and 
lower panel, 50 μ m.
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biomarker of this lung disease29. Therefore, it is conceivable that HIF2α -driven Club cell proliferation could also 
act as a cytoprotective axis to protect airway cells against oxidative stress and inflammation. Finally, recent studies 
also suggest the ability of HIF2α to initiate anti-inflammatory pathways. Indeed, HIF2α gene inactivation exac-
erbates pulmonary eosinophilic inflammation upon cobalt chloride-induced lung injury26. Therefore, it could be 
considered firstly that potentiation of HIF2α could attenuate lung dysfunction in COPD by counteracting asso-
ciated oxidative stress, cell damage and inflammation, and secondly a possible contribution of HIF2α -induced 
Club cell proliferation.
Regarding the molecular mechanisms underlying hypoxia-mediated changes in cell proliferation, we mainly 
focused on the role of HIF2α since hypoxia-induced bronchial epithelial cell proliferation is completely impaired 
upon HIF2α gene inactivation, and also that HIF2α expression and activity are induced in bronchial epithelial 
cells (Fig. 3A–C). This fits well with the finding that HIF2α is highly abundant in the lung23,31, and particularly so 
in airway cells as shown in this study. Previous studies have demonstrated a role for HIF1α in pulmonary hyper-
tension induced upon chronic exposure to the same hypoxic conditions (10% O2) as used in our study24,46. We 
cannot rule out the possibility that HIF1α is also active in bronchial epithelial cells in our hypoxia-exposed mice. 
In this line, it is conceivable that both isoforms are not induced to the same extent at a given oxygen tension (i.e. 
10% O2 in our study). Consistent with this notion, a previous study showed that pulmonary expression of HIF1α 
in ventilated lungs requires more severe hypoxia than 10% O246, which could reflect perhaps different sensitivities 
of each isoform to the levels of pulmonary hypoxia. In this regard, other studies have also shown that HIF2α 
can be induced at more modest hypoxic conditions than HIF1α 47. It is conceivable that HIF2α stabilization in 
hypoxic lungs requires milder hypoxic oxygen tensions than HIF1α , and perhaps HIF2α activity is more prom-
inent than HIF1α at the hypoxic conditions required to promote bronchial epithelial cell proliferation. It should 
also be considered that HIF1α acts as a repressor of cell proliferation in some biological settings11–14, which could 
potentially compromise HIF2α -dependent bronchial epithelial cell proliferation. Considering that the lung of Vhl 
deficient mice upregulates both HIF1α and HIF2α , as shown by western blotting22, it is plausible that a profound 
activation of HIF1α upon Vhl gene inactivation might explain, to some extent, the absence of proliferative bron-
chial epithelial cells in Vhl-deficient mice. Nevertheless, these recognized antiproliferative mechanisms executed 
by HIF1α are unlikely to be prevalent in hypoxic bronchial epithelium since the contrary response occurs, illus-
trated by the increased number of proliferative bronchial epithelial cells.
Regarding the potential molecular mechanisms executed by HIF2α to promote bronchial epithelial cell 
proliferation, we found a significant induction of HIF2α -dependent expression of FoxM1. In vitro studies have 
implicated this factor in hypoxia-induced PASMC proliferation48, but recent in vivo studies have shown that 
it is essential to confer Club cell proliferation and differentiation during embryonic development32,33. These in 
vivo studies as well as the concomitant appearance of Ki67positive and BrdUpositive Club cells and elevated FoxM1 
expression suggest its participation in HIF2α -dependent Club cell proliferation. Previous studies have shown 
oxygen-dependent regulation of RELMα 49,50. RELMα expression is driven by HIF2α and is localized in bronchial 
epithelium in hypoxic mice. Along this line, RELMβ , the only member of the resistin-like molecules expressed 
in human, can act as an airway-remodelling mediator promoting epithelial cell proliferation34, which might also 
contribute to HIF2α -dependent bronchial epithelium proliferation. A similar mechanism has been proposed to 
explain NSC proliferation through HIFs, but involving the release of extracellular HIF-dependent factors such 
as EPO and VEGF51,52. However, HIF2α can also act as a pro-proliferative factor in other scenarios, such as 
Vhl-deficient renal cell carcinoma or some stem cell niches, through a number cell-autonomous mechanisms 
including activation of genes involved in the cell cycle in addition to mTORC1 activation12,21,22,53,54.
Our findings, however, also indicate that mechanistically, Club cell proliferation is complex since constitutive 
activation of the PHD/HIF axis in Vhl-deficient mice as well as in DMOG-treated mice failed to induce Club cell 
proliferation. In particular, Vhl gene inactivation is sufficient to elevate HIF2α -dependent RELMα expression to 
a higher level that in hypoxia-exposed mice (Fig. 5A,B), although presumably FIH is still active. Along this line, 
a previous study has shown that hydroxylation of HIF2α by FIH is less efficient than hydroxylation of HIF1α 55. 
Therefore, it is possible that full activity of HIF2α is more easily achieved than HIF1α upon Vhl inactivation. 
These data reflect the fact that HIF2α activity is effectively induced in bronchial epithelium of Vhl-deficient mice, 
suggesting that failure to increase the number of Ki67-positive cells in the bronchial epithelium in Vhl-deficient 
mice cannot be simply attributed to inefficient HIF2α activation in these mice. However, it is still possible that 
the presumed persistent activity of FIH on HIF2α upon Vhl gene inactivation might preclude a full HIF2α acti-
vation required to promote bronchial epithelial cell proliferation. Indeed, some HIF dependent genes are par-
ticularly controlled by FIH8,56 and they could remain underexpressed in Vhl-deficient cells. In addition to these 
considerations, Vhl deficiency as well as DMOG treatment might affect other Vhl targets different from HIF 
factors, in addition to inhibition of other 2-oxoglutarate-dependent dioxygenases that could ultimately impede 
HIF2α -dependent bronchial epithelial proliferation. But our data also point to HIF-independent mechanisms. 
In this regard, recent studies show that carotid body (CB) sustentacular cell proliferation in hypoxic conditions 
requires HIF2α 57, but also a HIF-independent oxygen-sensing mechanism initiated in the adjacent neuron-like 
glomus cells type I cells58. Indeed, the appearance of BrdU-positive cells in the CB of hypoxic wild-type mice 
is severely impaired in hypoxic HIF2α -deficient mice57. However, in vivo administration of DMOG failed to 
promote such proliferative responses58. Similarly, a recent study has shown that glomus cells rapidly release 
endothelin-1 that acts on endothelin receptor-expressing type II cells to instruct their growth58,59. Therefore, 
similar to CB sustentacular cells, Club cell proliferation might involve HIF independent pathways, which could 
explain why constitutive pulmonary HIF2α activation is not sufficient to promote a full bronchial epithelium 
proliferative response.
In conclusion, our data show that in vivo exposure to hypoxia stress leads to a remarkable proliferation 
of bronchial epithelium mainly confined in Club cells, which can be regarded as a compensatory and adap-
tive response because Club cells have been previously associated with airway cell regeneration and protective 
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properties in pulmonary disease settings such as COPD. We also highlight the molecular complexity of this 
response involving the participation of HIF2α -dependent mechanisms, such as FoxM1 and RELMs, as well as 
HIF-independent mechanisms. Therefore, our findings establish a novel molecular link between hypoxic stress, 
HIF2α and Club bronchial epithelial cells, which are central in lung conducting airway biology.
Material and Methods
Ethics statement. All experimental procedures were approved by the Research Ethics Committee at the 
UAM and were carried out under the supervision of the Head of Animal Welfare and Health at the UAM in 
accordance with Spanish and European guidelines (RD 53/2013, 1 February 2013, and 2010/63/UE European 
Council Directive).
Animal models. Vhl floxed-Ubc-Cre-ERT2 mice and corresponding controls were generated as described60 
using C;129S-Vhlhtm1Jae/J mice (The Jackson Laboratory, stock no. 4081) and B6.Cg-Tg(UBC-Cre/ERT2)1Ejb/J 
mice (The Jackson Laboratory, stock no. 008085), which ubiquitously express a tamoxifen-inducible Cre recom-
binase (Cre-ERT2). Epas1tm1Mcs/J mice (The Jackson Laboratory, stock no. 008407) and B6.Cg-Tg(UBC-Cre/
ERT2)1Ejb/J mice were used to generate HIF2α floxed-UBC-Cre-ERT2 mice. Epas1tm1Mcs/J mice harbour two 
loxP sites flanking exon 2 of the murine HIF2α locus. For gene inactivation, mice were fed ad libitum with Teckland 
CRD TAM400/CreER tamoxifen pellets (Harlan Teklad) for 10-15 days and were later returned to standard mouse 
chow diet (Safe® , Augy, France). HIF2α floxed mice or Vhlfloxed lacking UBC-Cre-ERT2 were used as control mice.
In vivo hypoxic treatment and drug administration. Hypoxic conditions. To induce hypoxia in vivo, 
mice were placed in an airtight chamber with inflow and outflow valves, which was infused with a mixture of 10% 
O2, 90% N2 (S.E. Carburos Metalicos S.A) during 3–4 days.
DMOG treatment. DMOG (Enzo Lifesciences) was prepared in PBS. DMOG was administered once daily for 
3 days at a dose of 16 mg DMOG per mouse by intraperitoneal injection (i.p.). Control mice were injected in the 
same conditions with PBS. Mice were sacrificed 24 hours post injection after the last day.
BrdU Injection. Mice were exposed to normoxia or 10% hypoxia for four days. On the third and fourth day, mice 
were treated with 3 mg BrdU i.p. (Sigma). Mice were sacrificed 4 h after the second BrdU injection.
RNA extraction and qRT-PCR analysis and primers. Pulverized mouse lungs were processed as previ-
ously and snap-frozen in liquid nitrogen22. Lung tissue was homogenized in Trizol (Invitrogen) with two freeze/
thaw cycles and total RNA was isolated using the RNeasy RNA Extraction Kit (Qiagen). A cDNA template was 
prepared by reverse transcription of RNA (1 μ g) using Improm-II reverse transcriptase (Promega) and gene 
expression was then assessed using a Power SYBR Green PCR Master Mix kit (Applied Biosystems). Amplification 
data were analysed using StepOne Software version 2.0 (Applied Biosystems). The following mouse primer sets 
were used: Hprt1 (Fw 5′-GTTAAGCAGTACAGCCCCAAA-3′; Rv 5′-AGGGCATATCCAACAACAAACTT-3′), 
Hif2α (Fw 5′-ATGCCCTGGATTCGGAGA-3′; Rv 5′-GATACCACCTGCCCCTTGGT-3′), Relmα (Fw 5′-AA 
CTTCTTGCCAATCCAGCTAACTA-3′; Rv 5′-AGCCACAAGCACACCCAGTAG-3′); Relmβ (Fw 5′-CAAA 
GGATCAAGGAA GCTCTCAGT-3′; Rv 5′-AGCCATAGCCACAAGCACATC-3′); FoxM1 (Fw 5′-CACTT 
GGATTGAGGACCACTT-3′; Rv 5′-GTCGTTTCTGCTGTGATTCC-3′); Hgf (Fw 5′-CTGACACCCCTT 
GGGAGTATTG-3′; Rv 5′-GGTATTGCTGGT TCCCCTGTAA-3′), Egf (Fw 5′-CTTCAGGACCACAGCC 
ACTTTTA-3′; Rv 5′-ATCCAAGGCAAAAACCATTCC-3′) and Epo (Fw 5′-TCATCTGCGACAGTCGAG 
TTCT-3′; Rv 5′-TTTTCACTCAGTCTGGGACCTTCT-3′).
Western blotting. Pulverized mouse lungs were homogenized in RIPA buffer (50 mM Tris HCl, pH 7.4, 1% 
Triton X-100, 0.2% SDS, 1 mM EDTA) supplemented with an EDTA-free protease inhibitor (Roche) and protein 
extracts were quantified. Western blotting was performed using 15% SDS-polyacrylamide gels and membranes 
were probed with antibodies raised against β -actin (Santa Cruz, sc1616, 1:1000) and RELMα (Abcam, ab39626, 
1:1000). Blots were incubated with horseradish peroxidase-linked secondary antibodies and immunoreactivity 
was detected by enhanced chemiluminescence (SuperSignal West Femto Maximum Sensitivity Substrate, Thermo 
Scientific) and visualized with a digital luminescent image analyzer (Image Quant LAS4000 Mini; GE).
Histological Analysis. Lung tissue was embedded in paraffin after overnight fixation in 4% paraformalde-
hyde. Microwave-induced antigen retrieval (15′ at 240 W) was performed in 0.01 M sodium citrate (pH 6). For 
immunohistochemistry analysis, endogenous peroxidase was blocked with 3% H2O2 in methanol. Antibody 
binding was visualized using a LSAB + Peroxidase Kit with 3,3′ -diaminobenzidine as the chromogen (Dako). 
Sections were dehydrated and mounted with Eukitt mounting medium (Sigma-Aldrich). For immunohistochem-
istry and immunofluorescence, sections were stained overnight at 4 °C with antibodies against Ki67 (Abcam, 
ab16667,1:300 for IHC and 1:100 for IF), RELMα (Abcam, ab39626, 1:300 for IHC and 1:50 for IF), HIF2α 
(Abcam, ab199, 1:50), CC10 (Santa Cruz, sc9772, 1:50) and acetyl-tubulin (Sigma-Aldrich, clone 6-11B-1, 
1:3000). For immunodetection of BrdU positive cells, the antibody (BD Biosciences, 347580, 1:50) was incubated 
for 1 h at room temperature. The percentage of Ki67 and BrdU-positive cells in each experimental condition was 
calculated by counting bronchial epithelial cells in different bronchial airways of each mouse.
Statistics. Data were expressed as mean ± standard errors of the mean (SEM). All statistical analyses were per-
formed using GraphPad Prism 5 software. The differences between two groups with similar variances were analysed 
with a two-tailed Student´s t-test. One-way ANOVA with Tukey’s post-test was performed to compare the variance 
between multiple groups. A p value of < 0.05 was considered significant: * p < 0.05, ** p < 0.01 and ***p < 0.001.
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